Results 191 to 200 of about 10,372,945 (317)

Effects of Blood Components and Whole Blood in a Model of Severe Trauma-Induced Coagulopathy. [PDF]

open access: yesJ Surg Res, 2021
Stettler GR   +5 more
europepmc   +1 more source

Therapeutic applications of a novel humanized monoclonal antibody targeting chemokine receptor CCR9 in pancreatic cancer

open access: yesMolecular Oncology, EarlyView.
C–C chemokine receptor type 9 (CCR9) is an immune checkpoint in pancreatic ductal adenocarcinoma (PDAC). Novel anti‐CCR9 antibody SRB2 was evaluated in combination with cytotoxic chemotherapy in PDAC cells, patient‐derived organoids, patient‐derived xenografts, and humanized mouse models.
Hannah G. McDonald   +18 more
wiley   +1 more source

Leveraging Blood Components for 3D Printing Applications Through Programmable Ink Engineering Approaches. [PDF]

open access: yesAdv Sci (Weinh)
Sobreiro-Almeida R   +8 more
europepmc   +1 more source

Simultaneous inhibition of TRIM24 and TRIM28 sensitises prostate cancer cells to antiandrogen therapy, decreasing VEGF signalling and angiogenesis

open access: yesMolecular Oncology, EarlyView.
TRIM24 and TRIM28 are androgen receptor (AR) coregulators which exhibit increased expression with cancer progression. Both TRIM24 and TRIM28 combine to influence the response of castrate‐resistant prostate cancer (CRPC) cells to AR inhibitors by mediating AR signalling, regulation of MYC and upregulating VEGF to promote angiogenesis. Castrate‐resistant
Damien A. Leach   +8 more
wiley   +1 more source

miR-Blood - a small RNA atlas of human blood components. [PDF]

open access: yesSci Data
Jehn J   +21 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy